GEOVAX LABS INC
Geovax Labs Inc is a biotechnology company that develops immunotherapeutic vaccines and antibody seeking treatments to prevent and fight infectious diseases.
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying GEOVAX Labs' stock with a target price of $74, indicating significant growth potential.
Financial Health
GEOVAX Labs has modest revenue and cash flow but a low book value per share.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring GOVX
Pediatric Vaccine Rollout
This carefully selected group of stocks represents companies positioned to benefit from the full FDA approval of COVID-19 vaccines for at-risk children. Our professional analysts have identified opportunities across the entire value chain, from vaccine manufacturers to healthcare providers and clinical research organizations.
Published: July 11, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Platform Potential
Geovax’s MVA‑VLP platform underpins its vaccine candidates and could offer differentiation if clinical proof emerges, though outcomes are uncertain and long timelines are common.
Clinical Milestones
Trial data and regulatory updates are primary catalysts that can move the stock sharply in either direction; investors should expect binary event risk.
Funding & Liquidity
With a market capitalisation near $17m, Geovax is a micro‑cap with limited liquidity and potential need for further financing, which can dilute existing holders.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals develops treatments for diseases including cystic fibrosis and cancer.
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals is a leading biotechnology company that develops and manufactures innovative medicines for serious medical conditions.
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing therapeutics based on RNA interference (RNAi).
